CompanyApplied DNA Sciences, Inc.
United States of America
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and cont...
Private/Public:
public
Phone:(631) 240-8800
Fax:631-240-8900
Email:[email protected]
Website:http://adnas.com/
Address:50 Health Sciences Drive, Stony Brook, NY 11790, United States of America
Therapeutic Categories
Main Disease Areas
Product Groups
For Services/Products
API/Biologicals Production
API/Biologics development and manufacturing
Formulation
Formulation types
Bioanalytical
Bioanalytical Assay Services
Package and Label
Packaging Supplies
Specific Services - Packaging etc.
Diagnostics
Diagnostic assay development/manufacturing
Diagnostic Product Offerings
Diagnostic Testing Services - Genomic/Non-genomic
United States of America
- (12.May.2022) Applied DNA Reports Second Quarter Fiscal 2022 Financial Results
- (06.Apr.2022) Applied DNA Awarded NYC-Based 'Return-to-Office'
- (14.Mar.2022) Applied DNA Executes LOI With Spindle Biotech for Research Collaboration on Simplified High Yield mRNA Production System
- (24.Feb.2022) Applied DNA Announces Closing of $4.2 Million Registered Direct Offering
- (22.Feb.2022) Applied DNA Announces Pricing of $4.2 Million Registered Direct Offering
- (17.Feb.2022) Applied DNA and EvviVax Announce Publication of Positive Preclinical Data for LinearDNA Platform Approach to Cancer Immunotherapy
- (10.Feb.2022) Applied DNA First Quarter Fiscal 2022 Financial Results Feature Record Quarterly Revenues
- (28.Jan.2022) Applied DNA to Deploy Linea 1.0 COVID-19 Assay for Rapid Detection of New Omicron Subvariant BA.2
- (21.Jan.2022) Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea 2.0 COVID-19 Assay and Linea Unsupervised at-Home Sample Collection Kit
- (18.Jan.2022) Applied DNA Announces Continued Momentum in COVID-19 Testing Demand
- (04.Jan.2022) Applied DNA Receives New York State Department of Health Conditional Approval for Linea 2.0 COVID-19 Assay as Laboratory Developed Test
- (09.Dec.2021) Applied DNA Reports Fourth Quarter and Full Fiscal Year 2021 Financial Results, Continuing Momentum in Diagnostic Testing
- (06.Dec.2021) Applied DNA Advances Cotton Genomics-Based Methodology for Determination of Authenticity and Provenance
- (29.Nov.2021) Applied DNA Announces Strategy to Address Omicron SARS-CoV-2 Variant, Introduces Linea 2.0 COVID-19 Assay Kit
- (15.Nov.2021) Applied DNA Subsidiary LineaRx Receives Repeat Orders for LinearDNA, Adds Federally Funded Cancer Research Laboratory as CRO Customer
- (09.Nov.2021) Research Publication Demonstrates Utility of Applied DNA's LinearDNA in Non-Viral CAR T Manufacturing Systems
- (05.Nov.2021) Applied DNA and CLEARED4 Offer Fast, Cost-Effective and Turnkey Integrated Solution for Compliance With OSHA Mandate for COVID-19 Vaccination and Testing
- (25.Oct.2021) Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea SARS-CoV-2 Mutation Panel
- (20.Oct.2021) Ganesha Ecosphere and Applied DNA to Deploy CertainT Platform to Secure Recycled Polyester Supply Chain
- (12.Oct.2021) Applied DNA Implements safeCircle COVID-19 Testing Program at Sarah Lawrence College
- (14.Sep.2021) Applied DNA Announces CertainT Platform Support for TruTrace StrainSecure 2.0 for Next Generation Cannabis Tagging, Testing and Tracking
- (08.Sep.2021) Applied DNA Enters into Master Services Agreement with Flora Growth for Cannabis Validation and Authentication, Secures First Statement of Work Contract
- (02.Sep.2021) Applied DNA Awarded Suffolk County Community College COVID-19 Testing Contract
- (12.Aug.2021) Applied DNA Announces Third Quarter Fiscal 2021
- (03.Aug.2021) Applied DNA Awarded the City University of New York (CUNY) COVID-19 Testing Contract